The Law Offices of Frank R. Cruz announces an investigation of Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

In November 2020, Yatsen conducted its initial public offering (“IPO”), selling 58.75 million American Depository Shares (“ADS”) at $10.50 per ADS.

On August 26, 2021, during a second quarter 2021 analyst call, Yatsen disclosed that its cosmetic line, Perfect Diary, had been deteriorating, requiring the Company to “refocus.”

On this news, Yatsen’s stock fell $1.03, or 17.6%, to close at $4.81 per ADS on August 26, 2021, thereby injuring investors.

Then, on November 17, 2021, Yatsen released its third quarter 2021 financial results, revealing a significant decrease in gross sales from the Company’s cosmetics brands.

On this news, Yatsen’s stock fell $0.59, or 17.9%, to close at $2.70 per ADS on November 17, 2021.

On March 10, 2022, Yatsen released its fourth quarter and full year financial results for 2021, disclosing a decrease of 22.1% in net revenues and 17.2% in gross sales.

On this news, Yatsen’s stock fell $0.49, or 39.5%, to close at $0.75 per ADS on March 10, 2022, thereby injuring investors further.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Yatsen securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220926005764/en/